Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DX25F6XNW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $12,116
Award facts
- Contract value 100% obligated
- $12,115.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,115.65 for Jakafi 10 mg tablets (60-count units) by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This delivery order was issued without a set-aside designation, and performance will take place at the vendor's Park Ridge, Illinois facility. The award represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities worldwide.
Jakafi (ruxolitinib) is an FDA-approved medication used primarily to treat myelofibrosis and other myeloproliferative neoplasms. This delivery order supports the Department of Defense's pharmaceutical supply chain by providing essential medications to military healthcare systems. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical distribution network, leveraging its woman-owned small business status to compete effectively in federal procurement while maintaining a robust portfolio of pharmaceutical product deliveries across military and federal healthcare facilities nationwide.
Quick answers
Who was awarded contract SPE2DX25F6XNW?
SPE2DX25F6XNW was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 21, 2025.
How much is contract SPE2DX25F6XNW worth?
The government has obligated $12,116 on SPE2DX25F6XNW.
Is contract SPE2DX25F6XNW an order under another contract?
Yes. SPE2DX25F6XNW is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XNW competed?
The extent of competition for SPE2DX25F6XNW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award